What is Greenwind Holdings Inc?
operates as a development-stage company that focuses on the acquisition of investment possibilities.
NEWG · Verdict
Moderate reward · moderate risk
NEWG stands out on volatility and balance sheet, but watch the profitability signal.
Based on 75% data coverage
NEWG · Verdict
Above average
Current ratio 0.00
0% return on equity
Earnings +0.8% CAGR
Model-based scoring. For information only — not financial advice.
operates as a development-stage company that focuses on the acquisition of investment possibilities. The company was formerly known as NewGen BioPharma Corp. The company is listed on the OTCCE in USA, operating in the Financial Services sector, with a market capitalisation of 4.76K.
The scoring profile indicates limited reward potential at this time, with valuation and momentum offering the most support. Risk indicators are moderate, consistent with typical market exposure.
For informational purposes only. Not financial advice.